D-0871-2016 Class I Terminated
FDA drug recall D-0871-2016 was initiated by Pharmakon Pharmaceuticals on Feb 11, 2016 and is designated Class I. Reason for recall: Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj. The recall status is terminated (terminated May 16, 2017). Affected quantity: 75 Syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Jun 1, 2016
- Initiation Date
- Feb 11, 2016
- Termination Date
- May 16, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 75 Syringes
Product Description
Morphine Sulfate 0.5 mg/mL, Preservative Free in 0.9% Sodium Chloride, Rx, total volume 1 mL, This is a compounded drug, CII, IV Use, syringe, Pharmakon Pharmaceuticals, NDC 45183-0322-78.
Reason for Recall
Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.
Distribution Pattern
IN and IL
Code Information
Lot #: E52418EV11C, Exp 03/19/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0871-2016
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026